Clinical trials
Recruiting Phase 2/3 trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 9 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 4 |
| AbbVie | 2 |
| Bicara Therapeutics | 1 |
| Blueprint Medicines Corporation | 1 |
| CSL Behring | 1 |
| Celgene | 1 |
| Centre Leon Berard | 1 |
| Chiesi Farmaceutici S.p.A. | 1 |
| Daiichi Sankyo | 1 |
| Eikon Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 2 |
| Neoplasm Metastasis | 2 |
| Neoplasms | 2 |
| Urinary Bladder Neoplasms | 2 |
| Adenoma, Islet Cell | 1 |
| Atherosclerosis | 1 |
| Breast Neoplasms | 1 |
| Camurati-Engelmann Syndrome | 1 |
| Carcinoma, Transitional Cell | 1 |
| Colorectal Neoplasms | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.